| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | | Total Revenue |
-
|
-
| | Cost of Revenue |
-
|
-
| | | Gross Profit |
-
|
-
| | | Operating Expenses | | Research Development |
-
|
-
| | Selling General and Administrative | 831 | 10 | | Non Recurring |
-
|
-
| | Others |
-
|
-
| | | | Total Operating Expenses |
-
|
-
| | | | Operating Income or Loss | (831) | (10) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 2,470 |
-
| | Earnings Before Interest And Taxes | 1,639 | (10) | | Interest Expense | 1 | 2 | | Income Before Tax | 1,639 | (12) | | Income Tax Expense | 553 |
-
| | Minority Interest |
-
|
-
| | | | Net Income From Continuing Ops | 1,086 | (12) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| | Extraordinary Items |
-
|
-
| | Effect Of Accounting Changes |
-
|
-
| | Other Items |
-
|
-
| | | | Net Income | 1,086 | (12) | | Preferred Stock And Other Adjustments |
-
|
-
| | | Net Income Applicable To Common Shares | $1,086 | ($12) |
|
1.27% Nasdaq 
Income Statement
